FIELD: chemistry.
SUBSTANCE: invention relates to novel imidazole derivatives of formula 
where A is pyridinyl; and B is a condensed ring system consisting of: a. a phenyl ring bonded to a molecular residue, b. a second heterocyclic 5- or 6-member ring which is condensed with the phenyl ring, and has one nitrogen or oxygen atom, and to tautomeric forms thereof.
EFFECT: obtaining novel imidazole derivatives which are antagonists of adrenergic receptors.
6 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS OF ((PHENYL)IMIDAZOLYL)METHYL-HETEROARYL, USE THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS, AND KIT CONTAINING SUCH COMPOSITION | 2008 |
|
RU2478631C2 |
| ADRENERGIC COMPOUNDS | 2008 |
|
RU2491284C2 |
| 4-(PHENYLMETHYL AND SUBSTITUTED-PHENYLMETHYL)-IMIDAZOLE-2-THIONIES, ACTING AS SPECIFIC ALPHA-ADRENERGIC AGONISTS | 2005 |
|
RU2383535C2 |
| CONDENSED CARBOCYCLE SUBSTITUTED DIHYDROIMIDAZOLE DERIVATIVES USED FOR PAIN CONTROL OR MANAGEMENT OF GLAUCOMA-LIKE CONDITIONS | 2008 |
|
RU2481335C2 |
| HETEROCYCLIC INDANE DERIVATIVES USED TO CONTROL PAIN AND TREAT GLAUCOMOID STATE | 2008 |
|
RU2491278C2 |
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
| COMPOUND, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2237060C2 |
| SELECTIVE PROTEIN KINASE INHIBITORS | 2012 |
|
RU2612972C2 |
| METHOD OF ACTIVATION OF REGULATORY T-CELLS OF ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | 2011 |
|
RU2599495C2 |
| NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
